RecruitingNot ApplicableNCT06729944

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

50 participants

Start Date

Apr 27, 2023

Study Type

INTERVENTIONAL

Conditions

Hepatectomy NGS Stenosis of Bile Duct

Summary

The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether next-generation sequencing (NGS) — a powerful type of genetic analysis — can improve the diagnosis and characterization of tumors in the bile ducts and gallbladder (biliary tract cancers). Better genetic profiling could help match patients to targeted treatments. **You may be eligible if...** - You are 18 years of age or older - You have a tissue sample available with enough DNA for both standard pathology and genetic analysis (at least 20 ng of DNA) **You may NOT be eligible if...** - There are no specific exclusion criteria for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.